15/09/2026
Naser Al Yammahi, CEO of Hayat Biotech, has been ranked No. 25 in Forbes Middle East’s Top Healthcare Leaders 2026.
Throughout his career, Naser has helped translate the UAE’s biotechnology ambitions into tangible capabilities, from playing a central role in establishing Hayat-Vax, the first COVID-19 vaccine manufactured in the MENA region, to advancing manufacturing development in Abu Dhabi and Serbia.
Under his leadership, Hayat Biotech continues to expand internationally, strengthen local capabilities, enable technology transfer, and deliver essential healthcare solutions to communities with limited access.
This recognition reflects the vision and leadership helping position the UAE as a growing force in global biotechnology while advancing meaningful healthcare impact worldwide.Naser Al Yammahi